4th October 2021 | Pharma Updates
Drug firm allowed cost of France workshop for medicos as tax deduction
Evolutis India had filed an appeal with the Income Tax Appellate Tribunal as a amount of 12.79 lakh INR, incurred by it in FY2014-15, had been denied by the officer. These costs were to a great extent towards workshop held by the company in France.
5 drug companies collaborate for the trial of anti-viral Covid drug
Cipla, DRL, Emcure, Sun Pharma and Torrent have joined hands to conduct clinical trials of Molnupiravir.
Glenmark, Aurobindo Pharma recall drugs in United States
Glenmark and Aurobindo are recalling drugs in the US market because of reasons like a deviation from standard manufacturing protocols and the presence of foreign substance in one of the affected lots.
Sanofi gets CDSCO approval for Glargine
This insulin Glargine is used to control hyperglycemia in diabetic patients.
Aurobindo Pharma MD Resigns
Aurobindo Pharma Managing Director N Govindarajan has resigned due to personal reasons, according to sources.
UNGA President Got Covishield Vaccine
United Nations General Assembly President Abdulla Shahid said he had received both doses of India’s Covishield.
JCR Pharma, Takeda Pharma collaborate to commercialize Hunter Syndrome Therapy
According to the agreement, Takeda will commercialize JR-141 outside the US, Europe, Canada and other areas.